Beck Depression Inventory (BDI) scores, were used as the outcome variables. Results: In the escitalopram trial, both HAM-D and BDI response rates were highest in patients taking escitalopram and statins together and lowest in patients receiving neither medication. Logistic regression analyses revealed that statin use was significantly associated with higher response rates on both the HAM-D and BDI at 1 year whereas no such associations were found for escitalopram. In the naturalistic observational study, the response rates at 1 year did not differ significantly by statin use. Instead, HAM-D response rate was significantly higher in patients taking lipophilic statins than in those who did not. Conclusion: Statins may be effective for the treatment of depression independent of medical status and escitalopram use, and they may potentiate the antidepressant action of serotonergic antidepressants in patients with ACS. Medicine, Abstract Background: The present study aims at exploring the psychometric characteristics of the Korean version of the Depression and Somatic Symptoms Scale (DSSS) in a clinical outpatient sample. Method: Study participants were recruited from consecutive outpatients, 18 -65 years of age, who met the DSM-IV-TR diagnostic criteria for major depressive disorder (current MDD) or had suffered from major depressive disorder (life time diagnosis of MDD). The subjects completed DSSS. A psychiatrist evaluated the Montgomery-Åsberg Depression Rating Scale (MADRS), and the 17 items Hamilton Depression Rating Scale (HAMD). Results: In total, 203 psychiatric outpatients (142 women) were analyzed. The Korean version of the DSSS, which was confirmed to have had a two-factor structure, showed satisfactory evidences of both reliability and validity. DSSS is an excellent screening instrument of symptomatic remission (AUC=0.88), and a score of 22 was suggested as a cut-off score showing a non-full remission (sensitivity: 82.1%; specificity:81.4%). The number of somatic symptoms and the SS score were confirmed as excellent indicators of predicting the severity of depression. Conclusion: DSSS was confirmed as an instrument that can measure both depression and somatic symptoms simultaneously, and accurately. These features of DSSS may be useful in clinical practice settings or in the consultation fields. Key Words: DSSS, Depression, Psychometric validation, Cut-off score, Primary care
Abstract
Background: The present study aims at exploring the psychometric characteristics of the Korean version of the Depression and Somatic Symptoms Scale (DSSS) in a clinical outpatient sample. Method: Study participants were recruited from consecutive outpatients, 18 -65 years of age, who met the DSM-IV-TR diagnostic criteria for major depressive disorder (current MDD) or had suffered from major depressive disorder (life time diagnosis of MDD). The subjects completed DSSS. A psychiatrist evaluated the Montgomery-Åsberg Depression Rating Scale (MADRS), and the 17 items Hamilton Depression Rating Scale (HAMD). Results: In total, 203 psychiatric outpatients (142 women) were analyzed. The Korean version of the DSSS, which was confirmed to have had a two-factor structure, showed satisfactory evidences of both reliability and validity. DSSS is an excellent screening instrument of symptomatic remission (AUC=0.88), and a score of 22 was suggested as a cut-off score showing a non-full remission (sensitivity: 82.1%; specificity:81.4%). The number of somatic symptoms and the SS score were confirmed as excellent indicators of predicting the severity of depression. Conclusion: DSSS was confirmed as an instrument that can measure both depression and somatic symptoms simultaneously, and accurately. These features of DSSS may be useful in clinical practice settings or in the consultation fields. Key Words: DSSS, Depression, Psychometric validation, Cut-off score, Primary care
PS231
Frequency of depressive syndromes in elderly individuals with no cognitive impairment, mild cognitive impairment, and Alzheimer's disease dementia
